ARGX250117C690000
- 0.00
- 0.000.00%
argenx SE Newsroom
Express News | Argenx SE : Guggenheim Raises Target Price to $775 From $665
Express News | Argenx SE : Wedbush Raises Target Price to $665 From $655
Argenx Announces Approval of VYVDURA (Efgartigimod Alfa and Hyaluronidase-qvfc) in Japan for Adults With Chronic Inflammatory Demyelinating Polyneuropathy
Wells Fargo Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $723
Express News | Wells Fargo Maintains Overweight on Argenx, Raises Price Target to $723
Argenx Analyst Ratings
$1000 Invested In Argenx 5 Years Ago Would Be Worth This Much Today
Argenx Se (ARGX) Gets a Hold From UBS
Express News | Argenx : UBS Raises Target Price to $600 From $575
Leerink Partners Maintains Argenx SE(ARGX.US) With Buy Rating, Announces Target Price $635
Argenx Se: Promising Growth With Strategic Expansion and Clinical Advancements
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved With BHV-1300, Gains Analyst Approval
Stifel Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $772
Stifel Nicolaus Keeps Their Buy Rating on Argenx Se (ARGX)
Top Gap Ups and Downs on Monday: MU, AVGO, STLA and More
Here's Why Argenx SE (ARGX) Surged in Q3
Citi Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $681
Citi Reaffirms Their Buy Rating on Argenx Se (ARGX)
Looking Into Argenx's Recent Short Interest
Should You Increase Your Holdings in Argenx SE (ARGX)?